Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Strnad

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related MortalityCarolin V Schneider, Stefan Gross, Sriram Balasubramani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2024
Alcohol consumption and liver phenotype of individuals with alpha-1 antitrypsin deficiencyMalin Fromme, Carolin V Schneider, Nurdan Guldiken, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
Hepatology Communications|February 5, 2024
Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trialZoltan Czigany, Deniz Uluk, Sandra Pavicevic, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2025
Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkersKatharina Remih, Franziska-Maria Hufnagel, Anna Sophie Karl, et al.
Orphanet Journal of Rare Diseases|April 9, 2026
Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implicationsCraig P Hersh, Jeffrey H Teckman, Pavel Strnad, et al.
Hepatology (Baltimore, Md.)|February 20, 2016
Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein responseYoshiaki Sunami, Marc Ringelhan, Enikö Kokai, et al.
Nature Communications|July 8, 2022
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironmentKai Markus Schneider, Antje Mohs, Wenfang Gui, et al.
Annals of Surgery|August 2, 2021
Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death: Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD)Zoltan Czigany, Johann Pratschke, Jiří Froněk, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related MortalityCarolin V Schneider, Stefan Gross, Sriram Balasubramani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2024
Alcohol consumption and liver phenotype of individuals with alpha-1 antitrypsin deficiencyMalin Fromme, Carolin V Schneider, Nurdan Guldiken, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
Hepatology Communications|February 5, 2024
Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trialZoltan Czigany, Deniz Uluk, Sandra Pavicevic, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2025
Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkersKatharina Remih, Franziska-Maria Hufnagel, Anna Sophie Karl, et al.
Orphanet Journal of Rare Diseases|April 9, 2026
Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implicationsCraig P Hersh, Jeffrey H Teckman, Pavel Strnad, et al.
Hepatology (Baltimore, Md.)|February 20, 2016
Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein responseYoshiaki Sunami, Marc Ringelhan, Enikö Kokai, et al.
Nature Communications|July 8, 2022
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironmentKai Markus Schneider, Antje Mohs, Wenfang Gui, et al.
Annals of Surgery|August 2, 2021
Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death: Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD)Zoltan Czigany, Johann Pratschke, Jiří Froněk, et al.
Pageof 23